Renal Cell Carcinoma
. Ed(S): Bukowski, Ronald M.; Figlin, Robert A. (University Of California, Los Angeles, Usa); Motzer, Robert
€ 198.10
FREE Delivery in Ireland
Description for Renal Cell Carcinoma
Hardback. Editor(s): Bukowski, Ronald M.; Figlin, Robert A. (University of California, Los Angeles, USA); Motzer, Robert. Num Pages: 631 pages, 9 black & white illustrations, 41 colour illustrations, biography. BIC Classification: MJCL; MMN. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 35. Weight in Grams: 1201.
The third edition of this critically acclaimed book has updated and expanded the survey of clinical, biological and pathological management of localized and advanced renal cell carcinoma. Internationally renowned editors and contributors explore the latest developments in molecular genetics, focusing on the novel targets that have been discovered in epithelial renal tumors.
Comprehensive and authoritative, Renal Cell Carcinoma: Molecular Targets and Clinical Applications, Third Edition is the definitive text on the rapidly evolving landscape of experimental therapeutics, written and edited by leaders of the field.
Product Details
Format
Hardback
Publication date
2014
Publisher
Springer-Verlag New York Inc. United States
Number of pages
631
Condition
New
Number of Pages
613
Place of Publication
New York, United States
ISBN
9781493916214
SKU
V9781493916214
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
About . Ed(S): Bukowski, Ronald M.; Figlin, Robert A. (University Of California, Los Angeles, Usa); Motzer, Robert
Ronald M Bukowski MD Emeritus Staff Physician Cleveland Clinic Taussig Cancer Center Professor Emeritus of Medicine CCF Lerner College of Medicine of CWRU Robert Figlin MD Professor of Medicine and Biomedical Sciences Director, Division of Hematology Oncology Department of Medicine, Cedars-Sinai Medical Center Associate Director for Academic Programs Samuel Oschin Comprehensive Cancer Institute Professor Emeritus of Medicine and Urology ... Read more
Reviews for Renal Cell Carcinoma
From the book reviews: “This is an important reference for practicing medical oncologists, urologists, and researchers interested in the biology and therapy of this disease. … This book details the most recent research into the molecular targets of RCC and applications for clinical drug development. … It should be part of libraries for clinicians or basic scientists dealing with ... Read more